A number of preclinical studies have demonstrated significant cytotoxic efficacy for suicide gene therapy using MSCs and ADSCs expressing HSV-TK in animal models of GBM through various mechanisms, such as “bystander effect”, close association with tumor microvasculature, changing the protein cargo, and inducing a local immune reaction [7–11]. This evidence concerns the gene TKT and glioblastoma.